S'abonner

A prospective study of treatments for cervical intraepithelial neoplasia and fecundability - 26/07/20

Doi : 10.1016/j.ajog.2019.12.017 
Lauren A. Wise, ScD a, , Sydney K. Willis, MPH a, Rebecca B. Perkins, MD b, Amelia K. Wesselink, PhD a, Alexandra Klann, MPH a, Holly M. Crowe, MPH a, Kristen A. Hahn, PhD a, Ellen M. Mikkelsen, PhD c, Elizabeth E. Hatch, PhD a
a Department of Epidemiology, Boston University School of Public Health, Boston, MA 
b Department of Obstetrics and Gynecology, Boston University School of Medicine, Boston, MA 
c Department of Clinical Epidemiology, Aarhus University, Aarhus, Denmark 

Corresponding author: Lauren A. Wise, ScD.

Abstract

Background

Treatments for cervical intraepithelial neoplasia remove precancerous cells from the cervix by excising or ablating the transformation zone. Most studies show no association between cervical intraepithelial neoplasia treatments and fertility outcomes. However, only 2 studies have examined time to pregnancy, both using retrospective study designs, with 1 study showing no association and the other showing a 2-fold increased risk of infertility (time to pregnancy >12 months) following excisional or ablative treatment.

Objective

We examined the association between cervical intraepithelial neoplasia treatments and fecundability.

Materials and Methods

We analyzed data from Pregnancy Study Online (PRESTO), a prospective cohort study of North American pregnancy planners enrolled during 2013−2019. At baseline, women reported whether they ever had an abnormal Papanicolaou test result, the number of abnormal Papanicolaou test results, and their age at first abnormal Papanicolaou test result. They also reported whether they underwent diagnostic (colposcopy) or treatment (excisional or ablative) procedures, and their age at each procedure. We restricted analyses to 8017 women with 6 or fewer cycles of attempt time at enrollment who reported receiving a Papanicolaou test in the previous 3 years. We estimated fecundability ratios and 95% confidence intervals using proportional probabilities models adjusted for sociodemographics, healthcare use, smoking, number of sexual partners, history of sexually transmitted infections, and human papillomavirus vaccination.

Results

A history of abnormal Papanicolaou test results showed little association with fecundability (fecundability ratio, 1.00; 95% confidence interval, 0.95−1.06). Likewise, receipt of colposcopy or treatment procedures, and time since treatment were not materially associated with fecundability. Results were similar when stratified by age and smoking status.

Conclusion

We observed no appreciable association of self-reported history of abnormal Papanicolaou test results, colposcopy, treatments for cervical intraepithelial neoplasia, or recency of treatment with fecundability. These results agree with the majority of previous studies in indicating little effect of cervical intraepithelial neoplasia treatments on future fertility.

Le texte complet de cet article est disponible en PDF.

Key words : cervical intraepithelial neoplasia, cohort studies, epidemiology, fertility, Papanicolaou smear, prospective studies


Plan


 This study was funded by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Grants R21-HD072326, R01-HD086742, and R03-HD094117. The funding sources had no involvement in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the article for publication.
 The authors report no conflict of interest.
 Cite this article as: Wise LA, Willis SK, Perkins RB, et al. A prospective study of treatments for cervical intraepithelial neoplasia and fecundability. Am J Obstet Gynecol 2019;223:96.e1-15


© 2019  Elsevier Inc. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 223 - N° 1

P. 96.e1-96.e15 - juillet 2020 Retour au numéro
Article précédent Article précédent
  • Adenomyosis incidence, prevalence and treatment: United States population-based study 2006–2015
  • Onchee Yu, Renate Schulze-Rath, Jane Grafton, Kelly Hansen, Delia Scholes, Susan D. Reed
| Article suivant Article suivant
  • Patient-centered change in the day-to-day impact of postmenopausal vaginal symptoms: results from a multicenter randomized trial
  • Carolyn J. Gibson, Alison J. Huang, Joseph C. Larson, Caroline Mitchell, Susan Diem, Andrea LaCroix, Katherine M. Newton, Susan D. Reed, Katherine A. Guthrie

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.